|
Jun 21
|
Life Science Virtual Investor Forum Presentations Now Available for Online Viewing
|
|
Jun 18
|
Life Sciences Virtual Investor Forum Agenda Announced for June 20th
|
|
Nov 28
|
Orexo announces FDA acceptance of New Drug Application filing for OX124, a high-dose rescue medication for opioid overdose
|
|
Sep 5
|
Orexo to participate in Pareto Securities´ 14th Annual Healthcare Conference 2023
|